Administration of IL-2-PE40 via osmotic pumps prevents adjuvant induced arthritis in rats. Improved therapeutic index of IL-2-PE40 administered by continuous infusion

This publication has 13 references indexed in Scilit:

• Multichain Interleukin-2 Receptor: A Target for Immunotherapy in Lymphoma
  JNCI Journal of the National Cancer Institute, 1989
• Interleukin 2 (IL2) PE40 is cytotoxic to cells displaying either the p55 or p70 subunit of the IL2 receptor.
  Journal of Biological Chemistry, 1988
• Purification and Partial Characterization of an Interleukin 2-Pseudomonas Exotoxin Fusion Protein
  Nature Biotechnology, 1988
• Inhibition by cyclosporin A of streptococcal cell wall‐induced arthritis and hepatic granulomas in rats
  Arthritis & Rheumatism, 1986
• In Situ Characterization of Autoimmune Phenomena and Expression of HLA Molecules in the Pancreas in Diabetic Insulitis
  New England Journal of Medicine, 1985
• Interactions between T lymphocyte subsets supported by interleukin 2-rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats.
  The Journal of Immunology, 1984
• Induction of suppressor T cells by interleukin 2.
  The Journal of Immunology, 1984
• Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques.
  Gut, 1984
• Peripheral Blood and Intrathyroidal Mononuclear Cell Populations in Patients with Autoimmune Thyroid Disorders Enumerated using Monoclonal Antibodies*
  Journal of Clinical Endocrinology & Metabolism, 1983
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
  Nature, 1970